A Machine Learning Approach for Predicting Biochemical Outcome After PSMA-PET-Guided Salvage Radiotherapy in Recurrent Prostate Cancer After Radical Prostatectomy: Retrospective Study.

Abstract

Authors

• Ali Janbain
  European Hospital Georges-Pompidou., Clinical research unit, INSERM Clinical Investigation Center., Paris Cité University, Paris, France.
• Andrea Farolfi
  Division of Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
• Armelle Guenegou-Arnoux
  European Hospital Georges-Pompidou., Clinical research unit, INSERM Clinical Investigation Center., Paris Cité University, Paris, France.
• Louis Romengas
  European Hospital Georges-Pompidou., Clinical research unit, INSERM Clinical Investigation Center., Paris Cité University, Paris, France.
• Sophia Scharl
  Department of Radiation Oncology, University of Ulm, Ulm, Germany.
• Stefano Fanti
  Medicina Nucleare Metropolitana, Bld 30, AOU Policlinico S. Orsola-Malpighi, Via Massarenti, 9, 40138, Bologna, Italy.
• Francesca Serani
  Division of Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
• Jan C Peeken
  Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Ismaninger Straße 22, 81675 Munich, Germany; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Germany.
• Sandrine Katsahian
  AP-HP, Hôpital Européen Georges Pompidou, Unité de Recherche Clinique, APHP Centre, Paris, France.
• Iosif Strouthos
  Department of Radiation Oncology, German Oncology Center, University Hospital of the European University, Limassol, Cyprus.
• Konstantinos Ferentinos
  Department of Radiation Oncology, German Oncology Center, University Hospital of the European University, Limassol, Cyprus.
• Stefan A Koerber
  Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.
• Marco E Vogel
  Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.
• Stephanie E Combs
  Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Ismaninger Straße 22, 81675 Munich, Germany; Institute of Innovative Radiotherapy (iRT), Department of Radiation Sciences (DRS), Helmholtz Zentrum München, Ingolstaedter Landstrasse 1, 85764 Neuherberg, Germany; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Germany.
• Alexis Vrachimis
  Department of Nuclear Medicine, German Oncology Center - University Hospital of the European University, Limassol, Cyprus.
• Alessio Giuseppe Morganti
  Division of Radiation Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
• Simon Kb Spohn
  Department of Radiation Oncology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
• Anca-Ligia Grosu
  German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany.
• Francesco Ceci
  Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
• Christoph Henkenberens
  Department of Radiation Oncology, Hannover Medical School, Hannover, Germany.
• Stephanie Gc Kroeze
  Department of Radiation Oncology, University Hospital Zürich, University of Zurich, Zurich, Switzerland.
• Matthias Guckenberger
  Department of Radiation Oncology, University Hospital Zurich, Switzerland.
• Claus Belka
  Department of Radiation Oncology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
• Peter Bartenstein
  German Cancer Consortium, Heidelberg, Germany.
• George Hruby
  Department of Radiation Oncology, Northern Sydney Cancer Centre, Royal North Shore Hospital, Reserve Road, St Leonards, NSW, Australia.
• Louise Emmett
  Garvan Institute of Medical Research and Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.
• Ali Afshar Omerieh
  Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
• Nina-Sophie Schmidt-Hegemann
  Department of Radiation Oncology KSA-KSB, Cantonal Hospital Aarau, Aarau, Switzerland.
• Lucas Mose
  Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
• Daniel M Aebersold
  Department of Radiation Oncology, Inselspital, Bern University Hospital, and University of Bern, Freiburgstrasse, 3010, Bern, Switzerland.
• Constantinos Zamboglou
  German Cancer Consortium (DKTK), Partner Site Freiburg, Germany constantinos.zamboglou@uniklinik-freiburg.de.
• Thomas Wiegel
  Department of Radio Oncology, University Hospital Ulm, Ulm, Germany.
• Mohamed Shelan
  Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Keywords

External Resources